A. Senturk Et Al. , "Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.," Molecular & cellular proteomics : MCP , vol.21, pp.100417, 2022
Senturk, A. Et Al. 2022. Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.. Molecular & cellular proteomics : MCP , vol.21 , 100417.
Senturk, A., Sahin, A. T., Armutlu, A., Kiremit, M. C., Acar, O., Erdem, S., ... Bagbudar, S.(2022). Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.. Molecular & cellular proteomics : MCP , vol.21, 100417.
Senturk, Aydanur Et Al. "Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.," Molecular & cellular proteomics : MCP , vol.21, 100417, 2022
Senturk, Aydanur Et Al. "Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.." Molecular & cellular proteomics : MCP , vol.21, pp.100417, 2022
Senturk, A. Et Al. (2022) . "Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.." Molecular & cellular proteomics : MCP , vol.21, p.100417.
@article{article, author={Aydanur Senturk Et Al. }, title={Quantitative phosphoproteomics analysis uncovers PAK2 and CDK1 mediated malignant signaling pathways in clear cell Renal Cell Carcinoma.}, journal={Molecular & cellular proteomics : MCP}, year=2022, pages={100417} }